Navigate to
-
Clinical deep dive Disease state overview Myelodysplastic syndromes (MDS) are classified as disorders in which there are abnormal (dysplastic) hematopoietic stem cells in the bone marrow, leading...
-
Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators The purpose of the study was to create a methodological framework for using propensity score...
-
Clinical deep dive Disease state overview MacTel type 2 is a rare neurodegenerative disease that affects the macula, which processes central and color vision. It is a bilateral asymmetric...
-
Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 References PTC Therapeutics announces FDA acceptance and Priority Review of the BLA for UpstazaTM. PTC...
-
Empowering client, providers and members 2024: Using real-time pricing, Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member....
-
Event features discussions about health care industry trends, best practices and innovations
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Whitepaper Tab 1 Myth 1 Myth 2 Myth 3 Myth 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed nec ornare mi. Praesent ultrices ipsum eget est rutrum, eget congue orci molestie. Sed diam...
-
Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication, you’ll find critical pharmacy trend insights that will help you make...
-
Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care
Prime Article: Perspectives -
Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab Oncology Linvoseltamab, intravenous (IV) Regeneron Pharmaceuticals Proposed indications...
-
Home Our solutions Modern technology MyRxInsights Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and...
-
When you fill your specialty prescription, we automatically enroll you in our Care Specialists program. Our care specialists are pharmacists and nurses who are specially trained in your condition....
-
NMPI: National Medicaid Pooling Initiative We negotiate the best price available from the pharmaceutical industry on behalf of our participating clients. View resources Services we offer Our...
-
Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
PUBLICATIONS FDA Decisions Expected: May 2026 Your monthly synopsis of new drugs expected to hit the market Bio-Thera is awaiting FDA decision for BAT2506, a golimumab biosimilar candidate to...
-
Research awards AMCP Silver Award – Controlled Substances Triple Threat Overlapping Days: Relationship with Healthcare Utilization and Costs Academy of Managed Care Pharmacy: Annual Meeting AMCP...
-
Please enter a valid video URL. The URL can point to any video file or a Youtube video. Please enter a valid video URL. The URL can point to any video file or a Youtube video. Reimagine a PBM with...
-
cover image Explore emerging cell and gene therapies, rare disease innovation and payer strategies shaping the specialty pipeline. Prime Therapeutics /spring-2026-prime-therapeutics-report The...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report -
-
Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes
Prime Article: Perspectives